Skip to main content

Table 1 Immunoreactivity of VEGF according to clinicopathologic characteristics of the cervical carcinoma patients

From: Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy

 

No. of patients

VEGF expression

 

Variables

 

Positive

Negative

P

Total

29

15

14

 

Age

    

   ≥50 years

12

7

5

0.55

   < 50 years

17

8

9

 

Stage

    

   IB2

20

9

11

0.28

   IIA

9

6

3

 

Cervical tumor size

    

   ≥5 cm

14

9

5

0.19

   < 5 cm

15

6

9

 

Clinical node involvement

    

   Yes

11

7

4

0.32

   No

18

8

10

 

SCC Ag level

    

   ≥5 ng/ml

14

8

6

0.57

   < 5 ng/ml

15

7

8

 
  1. a(n = 29)
  2. aThe P-value was determined using Chi-square test or Fisher's exact test.